Drug
Levalbuterol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Impaired Quality Of Life | 51 | 27.6 | 28.1 | signal |
| 2 | Blood Calcium Decreased | 30 | 20.7 | 20.9 | signal |
| 3 | Seasonal Allergy | 31 | 17.1 | 17.3 | signal |
| 4 | Orthostatic Hypotension | 34 | 15.2 | 15.3 | signal |
| 5 | Asthma | 206 | 14.3 | 15.4 | signal |
| 6 | Chronic Obstructive Pulmonary Disease | 87 | 13.0 | 13.4 | signal |
| 7 | Acute Respiratory Failure | 29 | 11.8 | 11.9 | signal |
| 8 | Infusion Site Pain | 18 | 11.0 | 11.0 | signal |
| 9 | Respiratory Tract Infection | 32 | 9.6 | 9.7 | signal |
| 10 | Sedation | 32 | 9.5 | 9.6 | signal |
| 11 | Sputum Discoloured | 11 | 9.0 | 9.1 | signal |
| 12 | Candida Infection | 19 | 8.9 | 8.9 | signal |
| 13 | Productive Cough | 48 | 7.9 | 8.0 | signal |
| 14 | Iron Deficiency Anaemia | 9 | 7.6 | 7.6 | signal |
| 15 | Secretion Discharge | 12 | 7.5 | 7.6 | signal |
| 16 | Brain Fog | 14 | 7.5 | 7.5 | signal |
| 17 | Upper Respiratory Tract Infection | 44 | 7.4 | 7.5 | signal |
| 18 | Loss Of Personal Independence In Daily Activities | 44 | 7.2 | 7.3 | signal |
| 19 | End Stage Renal Disease | 17 | 7.2 | 7.2 | signal |
| 20 | Laryngitis | 10 | 7.2 | 7.2 | signal |
| 21 | Bronchospasm | 13 | 7.1 | 7.1 | signal |
| 22 | Respiratory Tract Congestion | 14 | 6.8 | 6.9 | signal |
| 23 | Aphonia | 12 | 6.7 | 6.7 | signal |
| 24 | Flank Pain | 8 | 6.6 | 6.7 | signal |
| 25 | Bacteraemia | 10 | 6.6 | 6.6 | signal |
| 26 | Oxygen Saturation Decreased | 46 | 6.4 | 6.5 | signal |
| 27 | Vitamin D Deficiency | 8 | 6.4 | 6.4 | signal |
| 28 | Bronchitis | 61 | 6.4 | 6.5 | signal |
| 29 | Sinus Congestion | 11 | 6.3 | 6.3 | signal |
| 30 | Depressed Level Of Consciousness | 32 | 6.3 | 6.4 | signal |
| 31 | Sinusitis | 83 | 6.3 | 6.4 | signal |
| 32 | Ear Infection | 21 | 6.1 | 6.2 | signal |
| 33 | Dysphonia | 46 | 6.1 | 6.2 | signal |
| 34 | Wheezing | 46 | 6.0 | 6.1 | signal |
| 35 | Oral Candidiasis | 10 | 6.0 | 6.0 | signal |
| 36 | Illness | 76 | 5.9 | 6.0 | signal |
| 37 | Haemoptysis | 21 | 5.8 | 5.9 | signal |
| 38 | Sleep Disorder Due To A General Medical Condition | 12 | 5.8 | 5.8 | signal |
| 39 | Aspiration | 8 | 5.7 | 5.8 | signal |
| 40 | Small Intestinal Obstruction | 9 | 5.7 | 5.7 | signal |
| 41 | Supraventricular Tachycardia | 7 | 5.7 | 5.7 | signal |
| 42 | Pharyngeal Swelling | 7 | 5.7 | 5.7 | signal |
| 43 | Chronic Kidney Disease | 56 | 5.7 | 5.8 | signal |
| 44 | Pneumonia | 234 | 5.6 | 6.1 | signal |
| 45 | Cognitive Disorder | 33 | 5.5 | 5.6 | signal |
| 46 | Pneumothorax | 11 | 5.4 | 5.4 | signal |
| 47 | Viral Infection | 22 | 5.1 | 5.2 | signal |
| 48 | Decreased Activity | 7 | 5.1 | 5.1 | signal |
| 49 | Device Delivery System Issue | 17 | 5.1 | 5.1 | signal |
| 50 | Hepatic Encephalopathy | 6 | 5.0 | 5.0 | signal |
| 51 | Dyspnoea Exertional | 24 | 5.0 | 5.0 | signal |
| 52 | Impaired Gastric Emptying | 8 | 4.9 | 4.9 | signal |
| 53 | Dermatitis Contact | 7 | 4.8 | 4.8 | signal |
| 54 | Heart Rate Increased | 61 | 4.8 | 4.9 | signal |
| 55 | Dyspnoea | 348 | 4.8 | 5.3 | signal |
| 56 | Cough | 171 | 4.7 | 5.0 | signal |
| 57 | Insurance Issue | 9 | 4.7 | 4.7 | signal |
| 58 | Pulmonary Mass | 9 | 4.7 | 4.7 | signal |
| 59 | Sinus Disorder | 12 | 4.7 | 4.7 | signal |
| 60 | Renal Injury | 18 | 4.7 | 4.7 | signal |
| 61 | Throat Tightness | 16 | 4.6 | 4.6 | signal |
| 62 | Covid-19 Pneumonia | 7 | 4.6 | 4.6 | signal |
| 63 | Respiratory Distress | 16 | 4.5 | 4.5 | signal |
| 64 | Oral Herpes | 11 | 4.4 | 4.4 | signal |
| 65 | Throat Irritation | 25 | 4.3 | 4.4 | signal |
| 66 | Paraesthesia Oral | 8 | 4.3 | 4.3 | signal |
| 67 | Balance Disorder | 48 | 4.3 | 4.4 | signal |
| 68 | Leukocytosis | 10 | 4.3 | 4.3 | signal |
| 69 | Pulmonary Arterial Hypertension | 8 | 4.3 | 4.3 | signal |
| 70 | Rib Fracture | 11 | 4.2 | 4.2 | signal |
| 71 | Respiratory Disorder | 16 | 4.1 | 4.2 | signal |
| 72 | Oropharyngeal Pain | 49 | 4.1 | 4.2 | signal |
| 73 | Pulmonary Hypertension | 11 | 4.1 | 4.1 | signal |
| 74 | Seizure | 60 | 4.1 | 4.1 | signal |
| 75 | Product Taste Abnormal | 7 | 4.0 | 4.1 | signal |
| 76 | Tachypnoea | 7 | 4.0 | 4.0 | signal |
| 77 | Therapeutic Product Effect Incomplete | 36 | 4.0 | 4.0 | signal |
| 78 | Oral Discomfort | 7 | 3.9 | 3.9 | signal |
| 79 | Mobility Decreased | 36 | 3.9 | 3.9 | signal |
| 80 | Bladder Disorder | 5 | 3.9 | 3.9 | signal |
| 81 | Wrist Fracture | 6 | 3.9 | 3.9 | signal |
| 82 | Emphysema | 5 | 3.8 | 3.8 | signal |
| 83 | Sneezing | 11 | 3.8 | 3.8 | signal |
| 84 | Eyelid Ptosis | 5 | 3.8 | 3.8 | signal |
| 85 | Initial Insomnia | 5 | 3.8 | 3.8 | signal |
| 86 | Ear Discomfort | 5 | 3.8 | 3.8 | signal |
| 87 | Hospitalisation | 74 | 3.8 | 3.9 | signal |
| 88 | Product Odour Abnormal | 5 | 3.7 | 3.7 | signal |
| 89 | Petechiae | 5 | 3.7 | 3.7 | signal |
| 90 | Chest Discomfort | 49 | 3.7 | 3.8 | signal |
| 91 | Intentional Dose Omission | 13 | 3.7 | 3.7 | signal |
| 92 | Electrocardiogram Qt Prolonged | 17 | 3.7 | 3.7 | signal |
| 93 | Hypoaesthesia Oral | 7 | 3.6 | 3.6 | signal |
| 94 | Pharyngitis Streptococcal | 5 | 3.6 | 3.6 | signal |
| 95 | Clostridium Difficile Infection | 10 | 3.6 | 3.6 | signal |
| 96 | Nasal Congestion | 27 | 3.6 | 3.6 | signal |
| 97 | Pulmonary Thrombosis | 5 | 3.6 | 3.6 | signal |
| 98 | Nerve Compression | 4 | 3.4 | 3.4 | signal |
| 99 | Covid-19 | 76 | 3.3 | 3.4 | signal |
| 100 | Macular Degeneration | 5 | 3.3 | 3.3 | signal |
| 101 | Feeling Jittery | 8 | 3.3 | 3.3 | signal |
| 102 | Spinal Operation | 5 | 3.2 | 3.2 | signal |
| 103 | Inability To Afford Medication | 4 | 3.2 | 3.2 | no signal |
| 104 | Spinal Fracture | 8 | 3.1 | 3.1 | signal |
| 105 | Salivary Hypersecretion | 4 | 3.1 | 3.1 | no signal |
| 106 | Eye Discharge | 4 | 3.0 | 3.0 | no signal |
| 107 | Therapy Interrupted | 27 | 3.0 | 3.1 | signal |
| 108 | Product Use Complaint | 6 | 3.0 | 3.0 | signal |
| 109 | Knee Arthroplasty | 8 | 3.0 | 3.0 | signal |
| 110 | Anaphylactic Reaction | 21 | 3.0 | 3.0 | signal |
| 111 | Cardiac Failure Congestive | 31 | 3.0 | 3.0 | signal |
| 112 | Lung Infection | 6 | 3.0 | 3.0 | signal |
| 113 | Transfusion | 4 | 3.0 | 3.0 | no signal |
| 114 | Body Height Decreased | 4 | 2.9 | 2.9 | no signal |
| 115 | Product Dose Omission Issue | 104 | 2.8 | 2.9 | signal |
| 116 | Blindness Unilateral | 5 | 2.8 | 2.8 | no signal |
| 117 | Upper Limb Fracture | 7 | 2.7 | 2.7 | signal |
| 118 | Internal Haemorrhage | 4 | 2.7 | 2.7 | no signal |
| 119 | Incorrect Product Administration Duration | 7 | 2.7 | 2.7 | signal |
| 120 | Eye Pruritus | 11 | 2.6 | 2.6 | signal |
| 121 | Product Packaging Issue | 3 | 2.5 | 2.5 | no signal |
| 122 | Eye Inflammation | 3 | 2.5 | 2.5 | no signal |
| 123 | Complication Associated With Device | 4 | 2.3 | 2.4 | no signal |
| 124 | Mood Altered | 8 | 2.3 | 2.3 | signal |
| 125 | Needle Issue | 8 | 2.2 | 2.2 | no signal |
| 126 | Product Substitution Issue | 16 | 2.2 | 2.2 | signal |
| 127 | Product Packaging Quantity Issue | 3 | 2.1 | 2.1 | no signal |
| 128 | Dry Skin | 36 | 2.1 | 2.1 | signal |
| 129 | Therapeutic Response Shortened | 8 | 2.0 | 2.0 | no signal |
| 130 | Eye Irritation | 14 | 2.0 | 2.0 | no signal |
| 131 | Multiple Fractures | 4 | 1.9 | 1.9 | no signal |
| 132 | Intraocular Pressure Increased | 3 | 1.8 | 1.8 | no signal |
| 133 | Injection Site Rash | 7 | 1.8 | 1.8 | no signal |
| 134 | Product Dispensing Error | 5 | 1.8 | 1.8 | no signal |
| 135 | Product Dose Omission | 15 | 1.8 | 1.8 | no signal |
| 136 | Psoriatic Arthropathy | 9 | 1.7 | 1.7 | no signal |
| 137 | Exposure Via Skin Contact | 5 | 1.7 | 1.7 | no signal |
| 138 | Dermatitis Atopic | 11 | 1.7 | 1.7 | no signal |
| 139 | Injection Site Mass | 8 | 1.7 | 1.7 | no signal |
| 140 | Device Malfunction | 14 | 1.6 | 1.6 | no signal |
| 141 | Pancreatic Carcinoma | 6 | 1.6 | 1.6 | no signal |
| 142 | Accidental Underdose | 3 | 1.6 | 1.6 | no signal |
| 143 | Injection Site Warmth | 4 | 1.5 | 1.5 | no signal |
| 144 | Product Quality Issue | 26 | 1.5 | 1.5 | no signal |
| 145 | Drug Dose Omission By Device | 14 | 1.4 | 1.4 | no signal |
| 146 | Circumstance Or Information Capable Of Leading To Medication Error | 6 | 1.4 | 1.4 | no signal |
| 147 | Device Use Issue | 3 | 1.3 | 1.3 | no signal |
| 148 | Syringe Issue | 3 | 1.3 | 1.3 | no signal |
| 149 | Lung Neoplasm Malignant | 7 | 1.3 | 1.3 | no signal |
| 150 | Skin Burning Sensation | 12 | 1.3 | 1.3 | no signal |
| 151 | Drug Abuse | 14 | 1.3 | 1.3 | no signal |
| 152 | Product Storage Error | 14 | 1.3 | 1.3 | no signal |
| 153 | Injection Site Reaction | 11 | 1.2 | 1.2 | no signal |
| 154 | Device Issue | 13 | 1.2 | 1.2 | no signal |
| 155 | Injection Site Swelling | 11 | 1.1 | 1.1 | no signal |
| 156 | Product Complaint | 3 | 0.9 | 0.9 | no signal |
| 157 | Injection Site Pain | 36 | 0.9 | 0.9 | no signal |
| 158 | Breast Cancer Female | 3 | 0.9 | 0.9 | no signal |
| 159 | Injection Site Pruritus | 7 | 0.8 | 0.8 | no signal |
| 160 | Device Breakage | 4 | 0.8 | 0.8 | no signal |
| 161 | Device Use Error | 3 | 0.7 | 0.7 | no signal |
| 162 | Wrong Technique In Device Usage Process | 4 | 0.7 | 0.7 | no signal |
| 163 | Bladder Cancer | 3 | 0.4 | 0.4 | no signal |